FDA Approves First Drug to Treat Rare Metabolic Disorder ...Middle East

SILVER SPRING, Md., Nov. 23, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Oxlumo (lumasiran) as the first treatment for primary hyperoxaluria type 1 (PH1), a rare genetic disorder. This approval is a cumulation of the work of experts and community members...

Hence then, the article about fda approves first drug to treat rare metabolic disorder was published today ( Tuesday 24/11/2020 - 05:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Drug to Treat Rare Metabolic Disorder )

Also on site :

• Wardrobe.NYC Brings Its Minimalist Touch to H&M in New Capsule Collection
• Germany and France to take over EU’s largest tank maker
• Legendary ’90s Rocker Announces 2026 Tour Dates After Postponing Shows